Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antimicrobial report ‘should ring alarm bells’
The report analysed 2017 data on antimicrobial resistance submitted by 28 EU states.
Data shows growing resistance to salmonella and campylobacter 

Antimicrobials used to treat diseases that are transmitted between animals and humans are becoming less effective, according to a report by the European Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).

EU Commissioner for health and food safety, Vytenis Andriukaitis, said: “The report released today should ring – again – alarm bells. It shows that we are entering into a world where more and more common infections become difficult – or even sometimes impossible – to treat."

The report analysed 2017 data on antimicrobial resistance submitted by 28 EU states. It found that resistance to fluoroquinolones is so high in Campylobacter in some countries that they no longer work for the treatment of severe cases.

Most countries reported that Salmonella in humans is becoming increasingly resistant to fluoroquinolones. Multidrug resistance is high in Salmonella found in humans (28.3%) and animals, particularly in S. Typhimurium.

Mike Catchpole, ECDC’s chief scientist, said. “Now is the time to turn the tide on antimicrobial resistance, if we want to keep antibiotics working. It’s particularly worrying when it comes to combined resistance: even low proportions mean that many thousands of patients across the EU have limited treatment options for severe infections.”

Marta Hugas, EFSA’s chief scientist, said: “We have seen that when Member States have implemented stringent policies, antimicrobial resistance has decreased in animals. Annual reporting by European and national agencies includes noteworthy examples. This should serve as an inspiration for other countries.”

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.